Work

Evaluating the association of persistent or single-time point frequent productive cough with 12-month exacerbation rate in asthma and/or COPD

Year: 2024

Type: conference-abstract

DOI: 10.1183/13993003.congress-2024.pa3884

Authors: Hana Müllerová, Eleni Rapsomaniki, Deven Patel, Laura Belton, Rod Hughes, Jose Maria Olaguibel, Alberto Papi, Helen K Reddel, Stefan Franzén, Bradley Chipps, Richard Beasley, Christer Janson, - For The Novelty Scientific Community And The

Institutions: AstraZeneca (United Kingdom), AstraZeneca (United States), University of Ferrara, The University of Sydney, Woolcock Institute of Medical Research, Sydney Local Health District, Macquarie University, University of Gothenburg, Capital Allergy and Respiratory Disease Center, Medical Research Institute of New Zealand, Uppsala University

Language: English

Topic: Chronic Obstructive Pulmonary Disease (COPD) Research

Subfield: Pulmonary and Respiratory Medicine

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W4404098208

Cites:

Cited by:

Related to: 10